CliffBio
small molecule

SELEGILINE HYDROCHLORIDE

SELEGILINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameSELEGILINE HYDROCHLORIDE
Active ingredientSELEGILINE HYDROCHLORIDE
Strength5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 1997
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.